Literature DB >> 10397557

Granulocyte-macrophage colony-stimulating factor: potential therapeutic, immunological and antiretroviral effects in HIV infection.

S C Deresinski.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10397557     DOI： 10.1097/00002030-199904160-00003

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  8 in total

1.  Immune Reconstitution Strategies in HIV.

Authors:  Matthew R. Leibowitz; Ronald T. Mitsuyasu
Journal:  Curr Infect Dis Rep       Date:  2001-06       Impact factor: 3.725

Review 2.  Prospects for immune reconstitution in HIV-1 infection.

Authors:  N Imami; F Gotch
Journal:  Clin Exp Immunol       Date:  2002-03       Impact factor: 4.330

3.  A chimeric HIV-1 envelope glycoprotein trimer with an embedded granulocyte-macrophage colony-stimulating factor (GM-CSF) domain induces enhanced antibody and T cell responses.

Authors:  Thijs van Montfort; Mark Melchers; Gözde Isik; Sergey Menis; Po-Ssu Huang; Katie Matthews; Elizabeth Michael; Ben Berkhout; William R Schief; John P Moore; Rogier W Sanders
Journal:  J Biol Chem       Date:  2011-04-22       Impact factor: 5.157

4.  Immune response to hepatitis B vaccine in HIV-infected subjects using granulocyte-macrophage colony-stimulating factor (GM-CSF) as a vaccine adjuvant: ACTG study 5220.

Authors:  E T Overton; M Kang; M G Peters; T Umbleja; B L Alston-Smith; B Bastow; D Demarco-Shaw; M J Koziel; L Mong-Kryspin; H L Sprenger; J Y Yu; J A Aberg
Journal:  Vaccine       Date:  2010-06-23       Impact factor: 3.641

5.  GM-CSF Fails to Improve Immune Responses to Booster Hepatitis B Vaccination in HIV-Infected Individuals.

Authors:  Edgar T Overton; Somnuek Sungkanuparph; Michael Klebert; Michael Royal; Debra Demarco-Shaw; William G Powderly; Judith A Aberg
Journal:  Open Virol J       Date:  2011-10-14

6.  Granulocyte-macrophage colony-stimulating factor as an immune-based therapy in HIV infection.

Authors:  Pierre Antoine Brown; Jonathan B Angel
Journal:  J Immune Based Ther Vaccines       Date:  2005-05-18

7.  Chimeric HIV-1 envelope glycoproteins with potent intrinsic granulocyte-macrophage colony-stimulating factor (GM-CSF) activity.

Authors:  Gözde Isik; Thijs van Montfort; Maikel Boot; Viviana Cobos Jiménez; Neeltje A Kootstra; Rogier W Sanders
Journal:  PLoS One       Date:  2013-04-02       Impact factor: 3.240

8.  Granulocyte colony stimulating factor adjuvant role on the immunological response to hepatitis B vaccine in patients with cirrhosis: a double blind randomized placebo controlled trial.

Authors:  Kamran Bagheri Lankarani; Mozaffar Talebzadeh; Ahad Eshraghian; Seyed Ali Malek-Hosseini
Journal:  Hepat Mon       Date:  2014-05-07       Impact factor: 0.660
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.